Journal profile · Medicine-Oncology
Cancer Treatment and Research
ISSN 0927-3042 · eISSN 2509-8497 · Springer Nature
Cancer Treatment and Research: subscription journal; 15 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Cancer Treatment and Research is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Sarcoma Diagnosis and Treatment and Lymphoma Diagnosis and Treatment, together about 20.8% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
This book series provides detailed updates on the state of the art in the treatment of different forms of cancer and also covers a wide spectrum of topics of current research interest. Clinicians will benefit from expert analysis of both standard treatment options and the latest therapeutic innovations and from provision of clear guidance on the management of clinical challenges in daily practice. The research-oriented volumes focus on aspects ranging from advances in basic science through to new treatment tools and evaluation of treatment safety and efficacy. Each volume is edited and authored by leading authorities in the topic under consideration. In providing cutting-edge information on cancer treatment and research, the series will appeal to a wide and interdisciplinary readership.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology7.8%
- Sarcoma Diagnosis and TreatmentMedicine7.6%
- Lymphoma Diagnosis and TreatmentMedicine5.4%
- Ovarian cancer diagnosis and treatmentMedicine5.3%
- Hematopoietic Stem Cell TransplantationMedicine5.1%
- Head and Neck Cancer StudiesMedicine4.8%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.4%
- Viral-associated cancers and disordersMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q3 | 284/428 | 33rd |
| Cancer Research | Q4 | 189/233 | 19th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 81OpenAlex ·
- i10-index
- 986OpenAlex ·
- 2-year mean citedness
- 2.33OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 2,818 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 14 | 0 | 1,002 |
| 2025 | 15 | 0 | 1,760 |
| 2024 | 28 | 2 | 1,998 |
| 2023 | 98 | 4 | 2,204 |
| 2022 | 25 | 0 | 2,242 |
| 2021 | 34 | 0 | 2,398 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Listed in PubMed/Index Medicus Model summary
The series is listed in PubMed/Index Medicus.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 0927-3042
- Electronic ISSN
- 2509-8497
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Cancer Treatment and Research
Which databases index Cancer Treatment and Research?
According to LetPub and DOAJ records, Cancer Treatment and Research is indexed in Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Cancer Treatment and Research open access, and what is the APC?
Cancer Treatment and Research is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .